← Open Payments lookup

ERICA ZIMMERMAN: Open Payments

NPI 1922280650 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$272 in 11 payments from 8 companies in 2025. Trend: 2023 $370 · 2024 $668 · 2025 $272

Food & beverage: $272
CompanyPaymentsAmount
Astellas Pharma US Inc3$83
Regeneron Healthcare Solutions, Inc.2$34
Novartis Pharmaceuticals Corporation1$33
AstraZeneca Pharmaceuticals LP1$30
Bayer Healthcare Pharmaceuticals Inc.1$29
Daiichi Sankyo Inc.1$26
Eisai Inc.1$22
Tempus AI, Inc1$15

Products named: Vyloy, LIBTAYO, PLUVICTO, IMFINZI, Nubeqa, Xospata, Enhertu, Lenvima.

Industry payments across TX — which companies pay providers there.